期刊文献+

神经内镜与显微镜手术治疗垂体瘤疗效与安全性的Meta分析 被引量:1

Transnasal-Sphenoidal Neuroendoscopy and Microscopy in the Treatment of Pituitary Adenomas:A Meta Analysis
下载PDF
导出
摘要 目的:评价神经内镜和显微镜手术治疗垂体瘤的疗效和安全性。方法:检索建库至2019年3月PubMed、EMBASE、CNKI等全文数据库,通过RevMan5.3软件进行Meta分析。结果:共纳入29项随机对照试验,Meta分析结果显示:经神经内镜手术较显微镜手术切除垂体瘤在术中出血量、术后住院时间、肿瘤全切率、激素水平恢复、术后脑脊液漏、尿崩、出血、颅内感染、鼻中隔穿孔和垂体功能低下等方面具有明显优势,且差异具有统计学意义。结论:神经内镜相比显微镜手术治疗垂体瘤更加利于患者术后恢复,缩短术后住院时间,且在减少术后并发症方面有明显优势。 Objective:To systematically evaluate the efficacy and safety of Transnasal-sphenoidal neuroendoscopy and microscopy in the treatment of pituitary adenomas.Methods:Following the principle of evidence-based medicine,the full text databases were collected from Pubmed,CNKI from database establishment to March 2019,data were analyzed by RevMan 5.3.Results:A total of 29 randomized controlled trials(RCTs)were included,Meta-analysis showed that neuroendoscopy had obvious advantages over microscopic in terms of intraoperative bleeding volume,post-operative hospital stay,total tumor resection rate,post-operative cerebrospinal fluid leakage,diabetes insipidus,hemorrhage,intracranial infection,perforation of nasal septum and hypopituitarism,differences are statistically significant.Conclusion:Compared with microscope surgery,neuroendoscopy is more conducive to the recovery of patients after surgery,shortens the postoperative hospital stay,and has obvious advantages in reducing postoperative complications.
作者 文朋 程登贵 李梦芝 陈欢 WEN Peng;CHENG Deng-gui;LI Meng-zhi;CHEN Huan(The Third of Affiliated of Zunyi Medical University(Zunyi First People's Hospital),Guizhou Zunyi 563000;Affiliated Hospital of Zunyi Medical University,Guizhou Zunyi 563000)
出处 《中国医疗器械信息》 2021年第3期25-26,153,共3页 China Medical Device Information
关键词 神经内镜 显微镜 垂体瘤 META分析 endoscopic surgery microsurgery pituitary adenoma Meta analysis
  • 相关文献

参考文献4

二级参考文献61

  • 1毛棣华,朱雪明,刘振延,惠国桢,王之敏,吴思荣.脑垂体腺瘤156例免疫组化及超微结构研究[J].苏州医学院学报,1995,15(3):417-420. 被引量:3
  • 2李东原,赵丛海,赵兴利,田宇,吕民,邢影,张海波.垂体腺瘤侵袭性与临床特征相关性分析[J].中国实验诊断学,2005,9(6):856-858. 被引量:1
  • 3苏志鹏,吴哲褒,于春江.泌乳素腺瘤耐溴隐亭治疗的研究进展[J].中华神经外科杂志,2006,22(6):386-387. 被引量:8
  • 4滕梁红,卢德宏.WHO(2004)与WHO(2000)垂体肿瘤分类的比较[J].诊断病理学杂志,2007,14(3):161-163. 被引量:2
  • 5Song F,Altman DG,Glenny AM,ei al. Validity of indirect comparisonfor estimating efficacy of competing interventions: empirical evidencefrom published meta-analyses [J]. BMJ,2003,326(7387):472.
  • 6Glenny AM,Altman DG,Song F,et al. Indirect comparisons ofcompeting interventions [J]. Health Technol Assess,2005,9(26):1-134,iii-iv.
  • 7Song F,Loke YK,Walsh T,et al. Methodological problems in the use ofindirect comparisons for evaluating healthcare interventions: surveyof published systematic reviews [J]. BMJ,2009,338:b 1147.
  • 8Song F,Harvey I,Lilford R. Adjusted indirect comparison may be lessbiased than direct comparison for evaluating new pharmaceuticalinterventions [J]. J Clin Epidemiol,2008,61 (5):455-463.
  • 9Berlie HD’Kalus JS’Jaber LA. Thiazolidinediones and therisk of edema: a meta-analysis [J], Diabetes Res ClinPract,2007,76(2):279-89.
  • 10Boonen S,Lips F,Bouillon K,et al. Need for additional calcium toreduce the risk of hip fracture with vitamin d supplementation:evidence from a comparative metaanalysis of randomized controlledtrials [J]. J Clin Endocrinol Metab,2007,92(4):1415-23.

共引文献166

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部